FDA Logo Schizophrenia and bipolar disorder are major mental disturbances causing mood swings and withdrawal. More recently, the U.S Food and Drug Administration has approved the first generic versions of Zyprexa and Zyprexa Zydus for the treatment of schizophrenia and bipolar disorder. The medication is also known by the name olanzapine.

Inspite of the approval, the FDA has cautioned users to be wary of the potential risks and benefits of consuming this pill.

“The approval of generic olanzapine offers greater access to a widely used treatment for mental illnesses. Having affordable treatment options is good for patients with long-term illnesses that must be carefully managed,” commented Keith Webber, Ph.D., deputy director of the Office of Pharmaceutical Science in the FDA’s Center for Drug Evaluation and Research.

Olanzapine arrives with a boxed warning which suggests that the medicine could elevate the chances of death among senior people whose beliefs have lost touch with reality owing to psychosis, confusion and memory loss.

The aforesaid drug has not received the FDA’s approval for treating psychosis in elderly people with dementia. Other severe side-effects associated with olanzapine include high blood sugar commonly called hyperglycemia, high-lipid or cholesterol or triglycerides levels in the blood and weight gain.

Physicians ought to take a note of all these influences before prescribing this kind of drug. Dr. Reddy’s Laboratories and Teva Pharmaceuticals USA are the manufacturers of generic olanzapine tablets while the generic olanzapine orally disintegrating tablets will be produced by Apotex, Dr. Reddy’s Laboratories and Par Pharmaceuticals.